SIAS
BIO icon

Shine Investment Advisory Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Shine Investment Advisory Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$12K Hold
23
– – ﹤0.01% 522
2020
Q2 		$10K Sell
23
-3
-12% -$1.32K ﹤0.01% 548
2020
Q1 		$9K Hold
26
– – ﹤0.01% 525
2019
Q4 		$10K Buy
26
+9
+53% +$3.17K ﹤0.01% 567
2019
Q3 		$6K Hold
17
– – ﹤0.01% 635
2019
Q2 		$5K Hold
17
– – ﹤0.01% 613
2019
Q1 		$5K Hold
17
– – ﹤0.01% 622
2018
Q4 		$4K Hold
17
– – ﹤0.01% 619
2018
Q3 		$5K Buy
+17
New +$5.28K ﹤0.01% 602

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Shine Investment Advisory Services's BIO Position: Q3 2020 in Review

Shine Investment Advisory Services held its Bio-Rad Laboratories Class A (BIO) position steady in Q3 2020 at 23 shares worth $12K. The position accounts for ﹤0.01% of the portfolio, ranked #522.

Shine Investment Advisory Services first reported a position in BIO in Q3 2018 and has held it in 9 quarters since. 479 funds tracked by Wall St. Rank hold BIO as of Q3 2020.

  • Shine Investment Advisory Services held 23 shares of Bio-Rad Laboratories Class A worth $12K as of Q3 2020.
  • Shine Investment Advisory Services left its Bio-Rad Laboratories Class A share count unchanged in Q3 2020.
  • Bio-Rad Laboratories Class A made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #522 holding.
  • Shine Investment Advisory Services first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and has held it in 9 quarters since.
  • 479 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.